Search Results

There are 19570 results for: content related to: Differential regulation of hippocampal progenitor proliferation by opioid receptor antagonists in running and non-running spontaneously hypertensive rats

  1. Opioid antagonists for alcohol dependence

    Intervention Review

    The Cochrane Library

    Susanne Rösner, Andrea Hackl-Herrwerth, Stefan Leucht, Simona Vecchi, Manit Srisurapanont and Michael Soyka

    Published Online : 8 DEC 2010, DOI: 10.1002/14651858.CD001867.pub3

  2. Sustained-Release Naltrexone For Opioid Dependence

    Intervention Review

    The Cochrane Library

    Philipp Lobmaier, Hege Kornor, Nikolaj Kunoe and Arild Bjørndal

    Published Online : 23 APR 2008, DOI: 10.1002/14651858.CD006140.pub2

  3. Oral naltrexone maintenance treatment for opioid dependence

    Intervention Review

    The Cochrane Library

    Silvia Minozzi, Laura Amato, Simona Vecchi, Marina Davoli, Ursula Kirchmayer and Annette Verster

    Published Online : 13 APR 2011, DOI: 10.1002/14651858.CD001333.pub4

  4. Single- and Multiple-Dose Pharmacokinetics of Long-acting Injectable Naltrexone

    Alcoholism: Clinical and Experimental Research

    Volume 30, Issue 3, March 2006, Pages: 480–490, Joi L. Dunbar, 1 Ryan Z. Turncliff, 1 Qunming Dong, 1 Bernard L. Silverman, 1 Elliot W. Ehrich and 1 Kenneth C. Lasseter 2

    Version of Record online : 13 FEB 2006, DOI: 10.1111/j.1530-0277.2006.00052.x

  5. You have free access to this content
    Improving clinical outcomes for naltrexone as a management of problem alcohol use

    British Journal of Clinical Pharmacology

    Volume 76, Issue 5, November 2013, Pages: 632–641, Gary K. Hulse

    Version of Record online : 21 OCT 2013, DOI: 10.1111/j.1365-2125.2012.04452.x

  6. You have free access to this content
    In vivo pharmacological resultant analysis reveals noncompetitive interactions between opioid antagonists in the rat tail-withdrawal assay

    British Journal of Pharmacology

    Volume 149, Issue 8, December 2006, Pages: 1071–1082, E A Walker

    Version of Record online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0706946

  7. Opioid antagonists with minimal sedation for opioid withdrawal

    Intervention Review

    The Cochrane Library

    Linda Gowing, Robert Ali and Jason M White

    Published Online : 29 MAY 2017, DOI: 10.1002/14651858.CD002021.pub4

  8. You have free access to this content
    Opioid antagonists for smoking cessation

    Intervention Review

    The Cochrane Library

    Sean P David, Tim Lancaster, Lindsay F Stead, A. Eden Evins and Judith J Prochaska

    Published Online : 6 JUN 2013, DOI: 10.1002/14651858.CD003086.pub3

  9. Naltrexone and Dysphoria: Fact or Myth?

    The American Journal on Addictions

    Volume 11, Issue 2, Spring 2002, Pages: 151–160, Karen Miotto, Michael McCann, Janice Basch, Richard Rawson and Walter Ling

    Version of Record online : 18 FEB 2010, DOI: 10.1080/10550490290087929

  10. A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm

    Addiction Biology

    Volume 19, Issue 4, July 2014, Pages: 575–586, Sarah F. Cordery, Alistair Taverner, Irna E. Ridzwan, Richard H. Guy, M. Begoña Delgado-Charro, Stephen M. Husbands and Christopher P. Bailey

    Version of Record online : 14 DEC 2012, DOI: 10.1111/adb.12020

  11. Naltrexone Depot Formulations for Opioid and Alcohol Dependence: A Systematic Review

    CNS Neuroscience & Therapeutics

    Volume 17, Issue 6, December 2011, Pages: 629–636, Philipp P. Lobmaier, Nikolaj Kunøe, Michael Gossop and Helge Waal

    Version of Record online : 23 SEP 2010, DOI: 10.1111/j.1755-5949.2010.00194.x

  12. Naltrexone Alone and With Sertraline for the Treatment of Alcohol Dependence in Alaska Natives and Non-Natives Residing in Rural Settings: A Randomized Controlled Trial

    Alcoholism: Clinical and Experimental Research

    Volume 32, Issue 7, July 2008, Pages: 1271–1283, Stephanie S. O’Malley, Robert W. Robin, Aryeh L. Levenson, Iva GreyWolf, Lawrence E. Chance, Colin A. Hodgkinson, Denise Romano, Jane Robinson, Boris Meandzija, Verner Stillner, Ran Wu and David Goldman

    Version of Record online : 28 JUN 2008, DOI: 10.1111/j.1530-0277.2008.00682.x

  13. Hepatic Safety and Antiretroviral Effectiveness in HIV-Infected Patients Receiving Naltrexone

    Alcoholism: Clinical and Experimental Research

    Volume 36, Issue 2, February 2012, Pages: 318–324, Jeanette M. Tetrault, Janet P. Tate, Kathleen A. McGinnis, Joseph L. Goulet, Lynn E. Sullivan, Kendall Bryant, Amy C. Justice, David A. Fiellin and For the Veterans Aging Cohort Study Team

    Version of Record online : 28 JUL 2011, DOI: 10.1111/j.1530-0277.2011.01601.x

  14. Dissociation of μ-opioid receptor and CRF-R1 antagonist effects on escalated ethanol consumption and mPFC serotonin in C57BL/6J mice

    Addiction Biology

    Volume 21, Issue 1, January 2016, Pages: 111–124, Lara S. Hwa, Akiko Shimamoto, Tala Kayyali, Kevin J. Norman, Rita J. Valentino, Joseph F. DeBold and Klaus A. Miczek

    Version of Record online : 28 SEP 2014, DOI: 10.1111/adb.12189

  15. You have free access to this content
    Neutral antagonist activity of naltrexone and 6β-naltrexol in naïve and opioid-dependent C6 cells expressing a µ-opioid receptor

    British Journal of Pharmacology

    Volume 156, Issue 7, April 2009, Pages: 1044–1053, MF Divin, FA Bradbury, FI Carroll and JR Traynor

    Version of Record online : 13 FEB 2009, DOI: 10.1111/j.1476-5381.2008.00035.x

  16. Effects of Naltrexone Treatment for Alcohol-Related Disorders on Healthcare Costs in an Insured Population

    Alcoholism: Clinical and Experimental Research

    Volume 34, Issue 6, June 2010, Pages: 1090–1097, Henry R. Kranzler, Leslie B. Montejano, Judith J. Stephenson, Shaohung Wang and David R. Gastfriend

    Version of Record online : 5 APR 2010, DOI: 10.1111/j.1530-0277.2010.01185.x

  17. A systematic review and meta-analysis of naltrexone implants for the treatment of opioid dependence

    Drug and Alcohol Review

    Volume 33, Issue 2, March 2014, Pages: 115–128, Sarah Larney, Linda Gowing, Richard P. Mattick, Michael Farrell, Wayne Hall and Louisa Degenhardt

    Version of Record online : 3 DEC 2013, DOI: 10.1111/dar.12095

  18. Phase I study of injectable, depot naltrexone for the relapse prevention treatment of opioid dependence

    The American Journal on Addictions

    Volume 23, Issue 2, MarchߝApril 2014, Pages: 162–169, Wang Xuyi, Wang Juelu, Xiang Xiaojun, Li Haiyan, Liu Zheyuan, Gong Zhehui, Dong Guoming, Liu Gang, Li Jin and Hao Wei

    Version of Record online : 20 SEP 2013, DOI: 10.1111/j.1521-0391.2013.12085.x

  19. Examination of mortality rates in a retrospective cohort of patients treated with oral or implant naltrexone for problematic opiate use


    Volume 107, Issue 10, October 2012, Pages: 1817–1824, Erin Kelty and Gary Hulse

    Version of Record online : 17 MAY 2012, DOI: 10.1111/j.1360-0443.2012.03910.x

  20. Naltrexone in the treatment of opioid-dependent pregnant women: the case for a considered and measured approach to research


    Volume 108, Issue 2, February 2013, Pages: 233–247, Hendrée E. Jones, Margaret S. Chisolm, Lauren M. Jansson and Mishka Terplan

    Version of Record online : 4 APR 2012, DOI: 10.1111/j.1360-0443.2012.03811.x